National Center for Research Resources (NCRR): Metabolism, Inborn Errors trials
The registry lists 27 Metabolism, Inborn Errors studies with National Center for Research Resources (NCRR) as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 6Phase 2 8Phase 3 1Phase 4 1No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of a Phenylalanine Restricted Diet During Pregnancy to Prevent Symptoms in Offspring of Patients With PhenylketonuriaCompletedNCT00006142Not applicable
- Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase DeficiencyCompletedNCT00006061Not applicable
- Diagnostic and Screening Study of Genetic DisordersCompletedNCT00006057
- Study of the Pathogenesis of Porphyria Cutanea TardaCompletedNCT00005103
- Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial HypercholesterolemiaCompletedNCT00004809Phase 1
- Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute PorphyriaCompletedNCT00004789Phase 1/2
- Study of Nutritional Factors in PorphyriaCompletedNCT00004788
- Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial MyopathyCompletedNCT00004770Not applicable
- Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle DisordersCompletedNCT00004767Phase 2
- Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase ActivityCompletedNCT00004658Phase 2
- Genetic Study of SitosterolemiaCompletedNCT00004481
- Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of PorphyriaCompletedNCT00004398Phase 1
- Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of PorphyriaCompletedNCT00004397Phase 1
- Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute PorphyriasCompletedNCT00004396Phase 2
- Stem Cell Transplantation (SCT) for Genetic DiseasesCompletedNCT00004378Not applicable
- Study of Homocysteine Metabolism in HomocystinuriaCompletedNCT00004356
- Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic AcidemiaCompletedNCT00004353
- Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous XanthomatosisStatus unknownNCT00004346Phase 2
- Study of Tetrathiomolybdate in Patients With Wilson DiseaseCompletedNCT00004339Phase 3
- Study of Zinc for Wilson DiseaseCompletedNCT00004338Phase 4
- Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type ICompletedNCT00004333Phase 2
- Studies in Porphyria I: Characterization of Enzyme DefectsStatus unknownNCT00004331
- Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic AttacksCompletedNCT00004330Not applicable
- Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan DiseaseCompletedNCT00004314Phase 2
- Study of Treatment and Metabolism in Patients With Urea Cycle DisordersStatus unknownNCT00004307Phase 1
- Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher DiseaseCompletedNCT00004294Phase 1
- Phase II Study of Glucocerebrosidase in Patients With Gaucher DiseaseStatus unknownNCT00004293Phase 2